EGO Stock Analysis: Eldorado Gold | NYSE
Gold | NYSE, USA | Market Cap: 8.361m USD | 12M Return: 60% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 59.3M
EPS Trend: 95.4%
Qual. Beats: 2
Rev. Trend: 99.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Eldorado Gold Corporation is a Canadian mining company headquartered in Vancouver that engages in the exploration, development, and sale of mineral products, primarily gold, along with by-product production of silver, lead, and zinc. The company operates across three core jurisdictions-Turkey, Canada, and Greece-holding 100% interests in the Kisladag and Efemçukuru mines in Turkey, the Lamaque complex in Quebec, and multiple Greek operations including Olympias, Stratoni, Skouries, Perama Hill, and Sapes. The company was originally incorporated in 1996 under its former name Eldorado Corporation Ltd. before adopting its current name later that year, and has been publicly traded on the NYSE since 2003.
As a mid-cap Materials sector issuer within the GICS Gold sub-industry, Eldorados financial performance is closely linked to global gold prices, reserve quality, and production costs, with revenue typically denominated in U.S. dollars while operating costs are spread across the Canadian dollar, Turkish lira, and euro. The companys diversified geographic footprint across three countries is a common strategy among multi-asset gold producers aimed at reducing country-specific regulatory and operational risk.
- Gold price strength lifts margins and free cash flow
- Skouries Greece project commissioning drives production growth
- Turkey lira weakness and political risk pressures operating costs
| Net Income: 574.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.05 > 0.02 and ΔFCF/TA -5.46 > 1.0 |
| NWC/Revenue: 22.87% < 20% (prev 70.59%; Δ -47.72% < -1%) |
| CFO/TA 0.10 > 3% & CFO 691.4m > Net Income 574.3m |
| Net Debt (627.7m) to EBITDA (1.03b): 0.61 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (200.9m) vs 12m ago -2.73% < -2% |
| Gross Margin: 49.44% > 18% (prev 49.04%; Δ 0.40% > 0.5%) |
| Asset Turnover: 31.62% > 50% (prev 23.84%; Δ 7.78% > 0%) |
| Interest Coverage Ratio: 27.30 > 6 (EBIT TTM 773.3m / Interest Expense TTM 28.3m) |
| A: 0.07 (Total Current Assets 1.19b - Total Current Liabilities 732.5m) / Total Assets 6.70b |
| B: -0.21 (Retained Earnings -1.43b / Total Assets 6.70b) |
| C: 0.12 (EBIT TTM 773.3m / Avg Total Assets 6.33b) |
| D: 1.82 (Book Value of Equity 4.32b / Total Liabilities 2.38b) |
| Altman-Z'' = 2.48 = A |
| DSRI: 1.31 (Receivables 231.6m/125.2m, Revenue 2.00b/1.42b) |
| GMI: 0.99 (GM 49.04% / 49.44%) |
| AQI: 1.34 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.41 (Revenue 2.00b / 1.42b) |
| TATA: -0.02 (NI 574.3m - CFO 691.4m) / TA 6.70b) |
| Beneish M = -2.28 (Cap -4..+1) = BBB |
As of July 28, 2026, the stock is trading at USD 32.54 with a total of 1,151,349 shares traded. Over the past week, the price has changed by +17.35%, over one month by +4.56%, over three months by +2.36% and over the past year by +59.98%.
Current recommended Stop Loss: 30.30 (which is 6.9% or 1.4 ATR below the current price).
Eldorado Gold has received a consensus analysts rating of 3.44. Therefore, it is recommended to hold EGO.
- StrongBuy: 1
- Buy: 3
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 41 | 26% |
P/E Trailing = 10.6611
P/E Forward = 8.5251
P/S = 4.1886
P/B = 1.8377
P/EG = 5.958
Revenue TTM = 2.00b USD
EBIT TTM = 773.3m USD
EBITDA TTM = 1.03b USD
Long Term Debt = 1.18b USD (from longTermDebt, last quarter)
Short Term Debt = 52.5m USD (from shortTermDebt, last quarter)
Debt = 1.26b USD (from shortLongTermDebtTotal, last quarter) + Leases 13.3m
Net Debt = 627.7m USD (calculated: Debt 1.26b - CCE 629.7m)
Enterprise Value = 8.99b USD (8.36b + Debt 1.26b - CCE 629.7m)
Interest Coverage Ratio = 27.30 (Ebit TTM 773.3m / Interest Expense TTM 28.3m)
EV/FCF = -27.00x (Enterprise Value 8.99b / FCF TTM -332.9m)
FCF Yield = -3.70% (FCF TTM -332.9m / Enterprise Value 8.99b)
FCF Margin = -16.64% (FCF TTM -332.9m / Revenue TTM 2.00b)
Net Margin = 28.71% (Net Income TTM 574.3m / Revenue TTM 2.00b)
Gross Margin = 49.44% ((Revenue TTM 2.00b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 54.51% (prev 49.28%)
Tobins Q-Ratio = 1.34 (Enterprise Value 8.99b / Total Assets 6.70b)
Interest Expense / Debt = 2.25% (Interest Expense 28.3m / Debt 1.26b)
Taxrate = 21.92% (164.6m / 751.0m)
NOPAT = 603.8m (EBIT 773.3m * (1 - 21.92%))
Current Ratio = 1.62 (Total Current Assets 1.19b / Total Current Liabilities 732.5m)
Debt / Equity = 0.29 (Debt 1.26b / totalStockholderEquity, last quarter 4.32b)
Debt / EBITDA = 0.61 (Net Debt 627.7m / EBITDA 1.03b)
Debt / FCF = -1.89 (negative FCF - burning cash) (Net Debt 627.7m / FCF TTM -332.9m)
Total Stockholder Equity = 4.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.08% (Net Income 574.3m / Total Assets 6.70b)
RoE = 13.68% (Net Income TTM 574.3m / Total Stockholder Equity 4.20b)
RoCE = 14.37% (EBIT 773.3m / Capital Employed (Equity 4.20b + L.T.Debt 1.18b))
RoIC = 10.20% (NOPAT 603.8m / Invested Capital 5.92b)
WACC = 7.50% (E(8.36b)/V(9.62b) * Re(8.36%) + D(1.26b)/V(9.62b) * Rd(2.25%) * (1-Tc(0.22)))
Discount Rate = 8.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -36.27 | Cagr: -0.50%
[DCF] Fair Price = unknown (Cash Flow -332.9m)
EPS Correlation: 95.38 | EPS CAGR: 93.23% | SUE: 2.83 | # QB: 2
Revenue Correlation: 99.19 | Revenue CAGR: 33.84% | SUE: 0.53 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.59 | Chg30d=-23.04% | Revisions=+0% | Analysts=9
EPS next Quarter (2026-09-30): EPS=0.96 | Chg30d=-18.61% | Revisions=+0% | Analysts=6
EPS current Year (2026-12-31): EPS=3.70 | Chg30d=-11.22% | Revisions=-17% | GrowthEPS=+111.6% | GrowthRev=+46.3%
EPS next Year (2027-12-31): EPS=5.58 | Chg30d=-2.42% | Revisions=+17% | GrowthEPS=+50.7% | GrowthRev=+56.2%
[Analyst] Revisions Ratio: +0% (up=5, down=5)